Article
Serum discrimination and phenotype assessment of coronary artery disease patents with and without type 2 diabetes prior to coronary artery bypass graft surgery.
PloS one - 1 Jan 2020
Hocker James R, Lerner Megan, Lightfoot Stan A, Peyton Marvin D, Thompson Jess L, Deb Subrato, Reinersman Mathew, Hanas R Jane, Postier Russel G, Edil Barish H, Burkhart Harold M, Hanas Jay S
Abstract excerpt
Diabetes Mellitus (DM) accelerates coronary artery disease (CAD) and atherosclerosis, the causes of most heart attacks. The biomolecules involved in these inter-related disease processes are not well understood. This study analyzes biomolecules in the sera of patients with CAD, with and without type (T) 2DM, who are about to undergo coronary artery bypass graft (CABG) surgery. The goal is to develop methodology...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.